Sino Biopharmaceutical to Present Cancer Drug Phase II Trial Findings at 2024 AACR
Sino Biopharmaceutical to Present Cancer Drug Phase II Trial Findings at 2024 AACR
中国生物制药将在2024年AACR上公布抗癌药物二期试验结果
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册